Nornicotine
Latest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Yaupon Therapeutics
- Class Alkaloids; Nicotine replacement therapy; Small molecules
- Mechanism of Action Nicotinic receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain; Smoking withdrawal
Most Recent Events
- 09 May 2009 Pharmacodynamics data from a preclinical trial in Neuropathic pain presented at the 28th Annual Scientific Meeting of the American Pain Society (APS-2009)
- 20 Nov 2007 Pharmacodynamics data presented at the 37th Annual Meeting of the Society for Neuroscience (SfN-2007)
- 02 Feb 2005 Nornicotine is available for licensing (http://www.yaupontherapeutics.com)